Baillie Gifford UK and Worldwide Eq B
Unclassified SectorPricing frequency
Daily
Dealing cut off time
08:45
Type
OEIC
Yield
1.51%
NAV
190.80p
Income frequency
Semi-annually
Ongoing charge
0.49%
Latest actual NAV date
16-11-2026
ISIN
GB00BZ3G2B42
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| AstraZeneca PLC | 4.30 |
| Baillie Gifford Em Mkts Lead Coms C Acc | 3.40 |
| Baillie Gifford Emerging Mkts Gr C Acc | 3.00 |
| Standard Chartered PLC | 2.76 |
| HSBC Holdings PLC | 2.75 |
| Unilever PLC | 2.63 |
| Rio Tinto PLC Ordinary Shares | 2.51 |
| Marks & Spencer Group PLC | 1.99 |
| RELX PLC | 1.73 |
| Compass Group PLC | 1.73 |
Investment objective
The Sub fund aims to outperform (after deduction of costs) a composite index comprising 60% UK and 40% overseas equities, as stated in sterling over rolling five-year periods. The composite index is calculated by Baillie Gifford and comprises: 60% FTSE All-Share Index and 40% overseas indices. The overseas element is currently made up of 28% FTSE North America Index; 28% FTSE Europe (ex UK) Index; 28% MSCI Pacific Index and 16% MSCI Emerging Markets Index. The Sub-fund will invest at least 90% directly or indirectly in shares of UK and overseas companies. The indirect investment will be through collective investment schemes (including those managed or operated by the ACD). The Sub-fund will be actively managed and may invest in shares of companies from any country, sector and in shares of companies of any size, however the Sub-fund will have a bias to UK companies.